Source: Zacks

Core Laboratories: Here's Why Hold Strategy is Apt for Core Laboratories Stock Now

CLB benefits from strong international growth, high-margin projects and an efficient business model. However, stock underperformance, competition and U.S. market challenges pose risks.

Read full article »
Annual Revenue
$500M-1.0B
Employees
1.0-5.0K
David M. Demshur's photo - President & CEO of Core Laboratories

President & CEO

David M. Demshur

CEO Approval Rating

78/100

Read more